Navigation Links
Abbott Announces Continued Positive Results with Xience V,Everolimus Eluting Coronary Stent in Spirit Clinical Trials

sinesses. Abbott Vascular is uniquely focused on advancing the treatment of vascular disease and improving patient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development, and advancing medicine through training and education. Headquartered in Northern California, Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular and coronary products that are recognized internationally for their safety and effectiveness in treating patients with vascular disease.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.

XIENCE is a registered trademark of Abbott. TAXUS and PROMUS are registered trademarks of Boston Scientific.

CONTACT: Media, Karin Bauer Aranaz, +1-650-868-2999, or Financial, TinaVentura, +1-847-935-9390, both of Abbott

Web site: http://www.abbott.com/http://www.abbottvascular.com/presskit/

Ticker Symbol: (NYSE:ABT)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
4. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
5. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
6. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
7. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
8. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
9. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:8/28/2015)... 2015 Research and ... of the "Investigation Report on China,s Latanoprost ... Developed by Pharmacia & Upjohn in 1995, ... effectively reduces intraocular pressure. As the first pressure- ... trade name of Xalatan) entered China ...
(Date:8/28/2015)... , Aug. 28, 2015  Perrigo Company plc ... it has completed the acquisition of leading OTC brands ... €200 million. The transaction is a clear demonstration of ... Company,s leading European distribution network spanning 36 countries.  ... C. Papa commented, "We are excited to complete ...
(Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
Breaking Medicine Technology:China Latanoprost Market Investigation Report 2015-2019 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5
... VIEW, Calif. , Feb. 16 Alexza Pharmaceuticals, Inc. (Nasdaq: ... on Thursday, February 18, 2010 from 9:00 a.m. - ... meeting will include presentations from: , Thomas King - ... PhD - SVP, Research and Development, Alexza Pharmaceuticals Michael Lesem ...
... , REDWOOD CITY, Calif. ... provider of information solutions for life science researchers, today announced ... metabolomics workflow support in the latest release of IPA® software. ... increasingly complex developments in the diagnosis, treatment, and etiology of ...
Cached Medicine Technology:Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 2Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 3Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 4IPA Helps Researchers Utilize and Share Current Disease Knowledge Through New Dynamic Reporting Capability 2
(Date:8/28/2015)... ... , ... Saint Petersburg, FL —Pocket Protein™, a protein beverage ... gluten, lactose or caffeine in a convenient 2 oz. pouch that never needs ... Awards. , Five consumer packaged goods (CPG) products were selected by the SupplySide ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Nashville ... military veterans leading in business. Mr. Troy Mizell, Chairman of the Board ... Nashville Business Journal's 2015 Veterans Awards will recognize Nashville military veterans who, through ...
(Date:8/28/2015)... , ... August 28, 2015 , ... Northridge dentists ... Zoom teeth whitening. For just $199, patients can currently receive a one hour treatment ... teeth whitening procedures, but it includes a number of unique features that can turn ...
(Date:8/28/2015)... ... ... The newest therapy to receive orphan drug status for the treatment of malignant ... educational website Surviving Mesothelioma. Click here to read their article on MTG-201. ... from the FDA, will now head into Phase I clinical trials to establish its ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Plaintiffs ... as MDL 2545, Testosterone Replacement Therapy Products Liability Litigation, are in the midst ... custodial files the PSC may receive for corporate employees involved in the production ...
Breaking Medicine News(10 mins):Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4
... BOSTON July 1, 2008 A study by researchers ... prescribed dietary recommendations is associated with better glucose control in ... management has been focused around new medications and technologies," said ... published in the July issue of Diabetes Care . ...
... including polio,eradication, EVANSTON, Ill., July 1 Jonathan ... 1 as chair of The,Rotary Foundation of Rotary International, ... last remaining strongholds -- which include his,homeland., "I ... said Majiyagbe.,"It is abundantly clear to all of us ...
... Pittsburgh-based Foundation,Radiology Group (FRG) has signed ... and Knox County Hospital, Barbourville,KY, through which ... diagnostic,imaging professional services, effective July 1st., ... acute care 136-bed,hospital. It offers a wide ...
... In conjunction with,its second quarter 2008 earnings release (expected to ... CVD ) is pleased to invite you,to listen to its quarterly ... Thursday, July 31, 2008 at 9:00 a.m. ET., What: ... Presentation, When: ...
... School of Medicine have identified a potential new way ... DNA constructed to build antigens against flu, along with ... against various strains of the virus. This approach could ... could be easily and effectively dispensed in case of ...
... of certain malignancies , , TUESDAY, July 1 (HealthDay News) -- ... dimmer switch to stop a "cancer signal" from contributing to ... cure, and no one knows if they will even lead ... a pathway for scientists to follow as they determine which ...
Cached Medicine News:Health News:Dietary adherence associated with better glucose control in children with type 1 diabetes 2Health News:The Rotary Foundation's First African Trustee Chair Takes Office 2Health News:The Rotary Foundation's First African Trustee Chair Takes Office 3Health News:Foundation Radiology Group Signs Multi-Year Contracts for Diagnostic Services with Pineville Community and Knox County Hospitals 2Health News:Penn animal study identifies new DNA weapon against avian flu 2Health News:Penn animal study identifies new DNA weapon against avian flu 3Health News:Scientists Find Way to Dim Cancer Switch 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 19.0 mm and length 21 mm....
... The BacT/Alert 3D Select ... art, automated microbial detection system ... fluid and mycobacteria culturing. This ... data management or laboratory information ...
IDS Rapid ANA II System, a microbial identification system....
IDS Rapid One, a microbial identification system....
Medicine Products: